Signals of infected pancreatic necrosis from blood
Part of Digestive system clinical trials.
This trial collects blood samples from people with infected pancreatic necrosis to find patterns that help diagnose the condition. The goal is to reduce the need for invasive tests and start treatment faster.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 18 years old.
- You must have a diagnosis of necrotizing pancreatitis (a serious infection of the pancreas) confirmed by a special CT scan.
- You cannot have had repeated attacks of acute pancreatitis (sudden pancreas inflammation).
- You cannot have pancreatic cancer.
- You cannot be pregnant or breastfeeding.
- You cannot have had a solid organ transplant (like a kidney or liver transplant).
- You cannot have an immune deficiency disorder such as AIDS.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at specific blood “immune” signatures and how they relate to outcomes in people with acute pancreatitis. If you enroll early, it may help doctors better predict how the illness will go and identify who might need more care.
This study looks at specific blood markers during an acute pancreatitis episode to better understand the condition. It may help improve treatment for future patients.
This study tests a new blood test that looks for signs of infection in people with severe pancreatitis. It aims to more accurately detect if the dead pancreatic tissue has become infected, which could help doctors decide on treatment earlier.
This study looks at blood tests to find markers that may help detect and monitor pancreatic cancer. It compares people with pancreatic cancer to those with benign pancreatic conditions and healthy volunteers.
This study looks at a special analysis of your blood (called cfDNA fragmentomics) to help find and tell apart certain early pancreatic tumors. If you’re having surgery for one of the listed solid pancreatic tumors, this trial may use your blood samples to improve diagnosis.
This study looks for proteins in the blood that could help doctors tell the difference between pancreatic cancer and non-cancerous pancreatic conditions, such as chronic pancreatitis or benign cysts. By participating, you could help improve early and accurate diagnosis, which may lead to better outcomes for future patients.
Hear when a new Acute Pancreatitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.